Retrospective Analysis of Transcriptomic Differences between Triple-Negative Breast Cancer (TNBC) and non-TNBC
Objective: Triple-negative breast cancer (TNBC), which has no expression of estrogen receptor, progesterone receptor and HER2, is an aggressive subgroup. Molecular differences between TNBC and non-TNBC should be better understood to develop tailored treatment strategies. Materials and Methods: The e...
Saved in:
| Main Author: | Çağlar Berkel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Istanbul University Press
2024-05-01
|
| Series: | European Journal of Biology |
| Subjects: | |
| Online Access: | https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/2FFB617552FC44E6B8B4E53D0E5F8BEF |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Receptor Status Differences in Prognosis for Breast Cancer
by: Yelda Deligöz Bildacı, et al.
Published: (2024-07-01) -
Assessment of ESR1, PGR, ERBB2, and MKI67 mRNA in Hormone Receptor‐Positive Early Breast Cancer: A Cross‐Sectional Study
by: Hamid Rezvani, et al.
Published: (2025-07-01) -
Research progress on estrogen receptor-positive/progesterone receptor-negative breast cancer
by: Zhengjia Lu, et al.
Published: (2025-06-01) -
Assessment of the receptor status in primary breast cancer with synchronous loco regional metastases: prognostic and clinical role?
by: O. O. Gordeeva, et al.
Published: (2019-04-01) -
The Role of Genomics and Transcriptomics in Characterizing and Predicting Patient Response to Treatment in Triple Negative Breast Cancer (TNBC)
by: Franklin Eduardo Corea-Dilbert, et al.
Published: (2025-04-01)